CoChat

Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells

Aliyandi, Aldy, Reker-Smit, Catharina, Zuhorn, Inge S., Salvati, Anna · 2023 · Acta Biomaterialia
Cited by 18

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2022.11.010

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 53

  1. Wolfram, 2019, Clinical cancer nanomedicine, Nano Today, 25, 85, 10.1016/j.nantod.2019.02.005 · DOI · Paper page
  2. Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer., 17, 20, 10.1038/nrc.2016.108 · DOI · Paper page
  3. D'Mello, 2017, The evolving landscape of drug products containing nanomaterials in the United States, Nat. Nanotechnol., 12, 523, 10.1038/nnano.2017.67 · DOI · Paper page
  4. Degors, 2019, Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors, Acc. Chem. Res., 52, 1750, 10.1021/acs.accounts.9b00177 · DOI · Paper page
  5. Wilhelm, 2016, Analysis of nanoparticle delivery to tumours, Nat. Rev. Mater., 1, 1, 10.1038/natrevmats.2016.14 · DOI · Paper page
  6. Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat. Nanotechnol., 8, 137, 10.1038/nnano.2012.237 · DOI · Paper page
  7. Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat. Nanotechnol., 7, 779, 10.1038/nnano.2012.207 · DOI · Paper page
  8. Cedervall, 2007, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, Proc. Natl. Acad. Sci. U. S. A., 104, 2050, 10.1073/pnas.0608582104 · DOI · Paper page
  9. Monopoli, 2011, Physical−Chemical Aspects of Protein Corona: relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles, J. Am. Chem. Soc., 133, 2525, 10.1021/ja107583h · DOI · Paper page
  10. Cox, 2018, Evolution of Nanoparticle Protein Corona across the Blood–Brain Barrier, ACS Nano, 12, 7292, 10.1021/acsnano.8b03500 · DOI · Paper page
  11. Barrán-Berdón, 2013, Time Evolution of Nanoparticle–Protein Corona in Human Plasma: relevance for Targeted Drug Delivery, Langmuir, 29, 6485, 10.1021/la401192x · DOI · Paper page
  12. Frost, 2017, Real-time in situ analysis of biocorona formation and evolution on silica nanoparticles in defined and complex biological environments, Nanoscale, 9, 3620, 10.1039/C6NR06399C · DOI
  13. Hadjidemetriou, 2016, Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles, Nanoscale, 8, 6948, 10.1039/C5NR09158F · DOI · Paper page
  14. Cheon, 2019, The Future of Nanotechnology: cross-disciplined Progress to Improve Health and Medicine, Acc. Chem. Res., 52, 2405, 10.1021/acs.accounts.9b00423 · doi:10.1021/acs.accounts.9b00423
  15. Tenzer, 2013, Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology, Nat. Nanotechnol., 8, 772, 10.1038/nnano.2013.181 · DOI · Paper page
  16. Deng, 2011, Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation, Nat. Nanotechnol., 6, 39, 10.1038/nnano.2010.250 · DOI · Paper page
  17. Pelaz, 2015, Surface Functionalization of Nanoparticles with Polyethylene Glycol: effects on Protein Adsorption and Cellular Uptake, ACS Nano, 9, 6996, 10.1021/acsnano.5b01326 · DOI · Paper page
  18. Francia, 2019, Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles, ACS Nano, 13, 11107, 10.1021/acsnano.9b03824 · DOI · Paper page
  19. Kim, 2014, Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety, Nanoscale, 6, 14180, 10.1039/C4NR04970E · DOI
  20. Dobrovolskaia, 2016, Current understanding of interactions between nanoparticles and the immune system, Toxicol. Appl. Pharmacol., 299, 78, 10.1016/j.taap.2015.12.022 · DOI · Paper page
  21. Ritz, 2015, Protein Corona of Nanoparticles: distinct Proteins Regulate the Cellular Uptake, Biomacromolecules, 16, 1311, 10.1021/acs.biomac.5b00108 · DOI · Paper page
  22. Walkey, 2014, Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles, ACS Nano, 8, 2439, 10.1021/nn406018q · DOI · Paper page
  23. Yin, 2019, Intrapulmonary Cellular-Level Distribution of Inhaled Nanoparticles with Defined Functional Groups and Its Correlations with Protein Corona and Inflammatory Response, ACS Nano, 13, 14048, 10.1021/acsnano.9b06424 · DOI
  24. Lara, 2017, Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles, ACS Nano, 11, 1884, 10.1021/acsnano.6b07933 · DOI · Paper page
  25. Lo Giudice, 2016, situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry, Nat. Commun., 7, 13475, 10.1038/ncomms13475 · DOI · Paper page
  26. Lara, 2018, Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure, ACS Nano, 12, 4930, 10.1021/acsnano.8b02014 · DOI
  27. Leser, 1996, The paramyxovirus simian virus 5 hemagglutinin-neuraminidase glycoprotein, but not the fusion glycoprotein, is internalized via coated pits and enters the endocytic pathway, Mol. Biol. Cell., 7, 155, 10.1091/mbc.7.1.155 · DOI
  28. Meulendyke, 2005, Endocytosis Plays a Critical Role in Proteolytic Processing of the Hendra Virus Fusion Protein, J. Virol., 79, 12643, 10.1128/JVI.79.20.12643-12649.2005 · DOI
  29. Ito, 2014, Involvement of insulin-degrading enzyme in insulin-and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells, J. Alzheimer's Dis., 38, 185, 10.3233/JAD-122077 · DOI · Paper page
  30. Cihil, 2013, The Cell-based l-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins, J. Vis. Exp., 82, 50867
  31. Tham, 2017, Determining cell-surface expression and endocytic rate of proteins in primary astrocyte cultures using biotinylation, J. Vis. Exp., 2017, e55974
  32. Ito, 2020, Identification of cell-surface proteins endocytosed by human brain microvascular endothelial cells in vitro, Pharmaceutics, 12, 579, 10.3390/pharmaceutics12060579 · DOI
  33. Aliyandi, 2020, Effect of endothelial cell heterogeneity on nanoparticle uptake, Int. J. Pharm., 587, 10.1016/j.ijpharm.2020.119699 · DOI
  34. Gromnicova, 2016, Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues, PLoS ONE, 11, 10.1371/journal.pone.0161610 · DOI
  35. Aliyandi, 2021, Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells, ACS Biomater. Sci. Eng., 7, 5573, 10.1021/acsbiomaterials.1c00804 · DOI
  36. Bewersdorff, 2017, The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles, Int. J. Nanomed., 12, 2001, 10.2147/IJN.S124295 · DOI
  37. Weksler, 2005, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J., 19, 1872, 10.1096/fj.04-3458fje · DOI · Paper page
  38. Parent, 2014, An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium, Biochem. Biophys. Res. Commun., 450, 7, 10.1016/j.bbrc.2014.05.038 · DOI
  39. Lesniak, 2012, Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page
  40. Kim, 2015, Toxicity of silica nanoparticles depends on size, dose, and cell type, Nanomed. Nanotechnol. Biol. Med., 11, 1407, 10.1016/j.nano.2015.03.004 · DOI · Paper page
  41. Hühn, 2013, Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge, ACS Nano, 7, 3253, 10.1021/nn3059295 · DOI · Paper page
  42. Marano, 2011, Nanoparticles: molecular targets and cell signalling, Arch. Toxicol., 85, 733, 10.1007/s00204-010-0546-4 · DOI · Paper page
  43. Aliyandi, 2020, Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines, Front. Bioeng. Biotechnol., 8, 10.3389/fbioe.2020.599454 · DOI
  44. Elschenbroich, 2010, Isolation of cell surface proteins for mass spectrometry-based proteomics, Expert Rev. Proteomics., 7, 141, 10.1586/epr.09.97 · DOI
  45. Plow, 1991, Role of Cell-Surface Lysines in Plasminogen Binding to Cells: identification of α-Enolase as a Candidate Plasminogen Receptor, Biochemistry, 30, 1682, 10.1021/bi00220a034 · DOI · Paper page
  46. Tonigold, 2018, Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona, Nat. Nanotechnol., 13, 862, 10.1038/s41565-018-0171-6 · DOI · Paper page
  47. Francia, 2020, Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine, Beilstein J. Nanotechnol., 11, 338, 10.3762/bjnano.11.25 · DOI
  48. Caracciolo, 2013, Selective Targeting Capability Acquired with a Protein Corona Adsorbed on the Surface of 1,2-Dioleoyl-3-trimethylammonium Propane/DNA Nanoparticles, ACS Appl. Mater. Interfaces., 5, 13171, 10.1021/am404171h · DOI · Paper page
  49. Arosio, 2012, Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles, Curr. Med. Chem., 19, 3128, 10.2174/092986712800784748 · doi:10.2174/092986712800784748
  50. Wang, 2010, Integrin targeted drug and gene delivery, Expert Opin. Drug Deliv., 7, 159, 10.1517/17425240903468696 · DOI
  51. Zuhorn, 2007, Adhesion receptors mediate efficient non-viral gene delivery, Mol. Ther., 15, 946, 10.1038/mt.sj.6300139 · DOI
  52. Kim, 2021, Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis, ACS Nano
  53. Bauer, 2020, Cell-type-specific differences in KDEL receptor clustering in mammalian cells, PLoS ONE, 15, 10.1371/journal.pone.0235864 · DOI

Metadata

Authors
Aliyandi, A., Reker-Smit, C., Zuhorn, I. S., & Salvati, A.
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2023-01
Volume
155
Pages
507-520
ISSN
1742-7061
Cited by
18
References
4
Language
en
Licence
Funders
  • Universitair Medisch Centrum Groningen
  • European Research Council (637614)
  • Institut National de la Santé et de la Recherche Médicale

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.